• Nenhum resultado encontrado

J. Coloproctol. (Rio J.) vol.34 número3

N/A
N/A
Protected

Academic year: 2018

Share "J. Coloproctol. (Rio J.) vol.34 número3"

Copied!
4
0
0

Texto

(1)

jcoloproctol(rioj).2014;34(3):189–192

Journal

of

Coloproctology

w w w . j c o l . o r g . b r

Review

Article

Management

of

acute

colorectal

diseases

in

febrile

neutropenic

patients

Camila

Perazzoli

a

,

Marley

Ribeiro

Feitosa

a,∗

,

Lorena

Lobo

de

Figueiredo-Pontes

b

,

José

Joaquim

Ribeiro

da

Rocha

a

,

Belinda

Pinto

Simões

b

,

Omar

Féres

a

aDivisionofColoproctology,DepartmentofSurgeryandAnatomy,RibeirãoPretoMedicalSchool,UniversityofSãoPaulo(USP),

RibeirãoPreto,SP,Brazil

bDivisionofHematology,DepartmentofInternalMedicine,RibeirãoPretoMedicalSchool,UniversityofSãoPaulo(USP),RibeirãoPreto,

SP,Brazil

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received24April2014 Accepted17June2014 Availableonline8July2014

Keywords:

Febrileneutropenia Typhlitis

Analcanal

a

b

s

t

r

a

c

t

Patientswithhematologicmalignanciesare susceptibletoseriouscomplicationsdueto immunosuppression.Neutropenic-relatedinfectionisoneofthemajorcausesofmorbidity andmortalityinthisgroupofdiseases.Febrileneutropeniaisacommoncomplicationof thehematologicneoplasmitselforchemotherapy,andhasworseprognosisifprolonged (lastingmorethan7days)orsevere(neutrophilcountbelow500cellsper␮L).Amongthe

usualsitesofinfection,wehighlighttheneutropenicenterocolitisandperianalinfectionas gastrointestinalcomplicationsofgreaterinteresttothecolorectalsurgeon.Althoughmost casesrespondtoconservativetreatment,aportionofpatientswillneedsurgeryforcomplete recovery.

©2014SociedadeBrasileiradeColoproctologia.PublishedbyElsevierEditoraLtda.All rightsreserved.

Tratamento

das

doenc¸as

colorretais

agudas

no

paciente

neutropênico

febril

Palavras-chave:

Neutropeniafebril Tiflite

Canalanal

r

e

s

u

m

o

Ospacientescomneoplasiashematológicasestãosujeitosaumasériadecomplicac¸ões devidoàimunossupressão.Infecc¸ãoéumasdasprincipaiscausasdemorbidadee mor-talidadenessegrupodedoenc¸as.Aneutropeniafebriléumacomplicac¸ãofrequenteda própriadoenc¸aonco-hematológicaoudaquimioterapia,eapresentapiorprognósticose prolongada(durac¸ãoacimade7dias)ousevera(contagemdeneutrófilosinferiora500 células pormicrolitro).Dentre osfocosde infecc¸ãomaiscomunsdestacamosa entero-coliteneutropênicae ainfecc¸ãoperianalcomocomplicac¸ões demaiorinteresseparao

PerformedattheDepartmentofSurgeryandAnatomy,RibeirãoPretoMedicalSchool,UniversityofSãoPaulo(USP),SãoPaulo,SP, Brazil.

Correspondingauthor.

E-mail:marleyfeitosa@yahoo.com.br(M.R.Feitosa).

http://dx.doi.org/10.1016/j.jcol.2014.06.002

(2)

190

jcoloproctol(rioj).2014;34(3):189–192

cirurgiãocolorretal.Apesardegrandepartedoscasosapresentarboarespostaaotratamento conservador,umaparceladepacientesnecessitarádecirurgiaparacompletarecuperac¸ão. ©2014SociedadeBrasileiradeColoproctologia.PublicadoporElsevierEditoraLtda. Todososdireitosreservados.

Febrile

neutropenia

Neutropeniaisacommonfindinginpatientswith hematolog-icalmalignancies.Itoccursasamanifestationofthedisease oraconsequenceofimmunosuppressivetreatment.1Itis

usu-allydefinedasanabsoluteneutrophilcount(ANC)of1500or fewerneutrophilsper␮Lofblood.Patientsaffectedbyacute

leukemia,leukemicphaselymphomas,myelodisplastic syn-dromesandthosereceivinghighintensitychemotherapyor bonemarrowtransplantationconditioningregimensare espe-ciallypronetodevelopsevereneutropeniadefinedbyanANC oflessthan500cells/␮L.2

Theriskofseriousinfectionissignificantlyhigherif neu-tropeniaissevereorprolonged(morethansevendays)and themostcommonsitesare:skin,venouscatheters,dental dis-eases,oropharynx,gums,paranasalsinuses,lungs,abdomen, genitalsandperianalarea.2 Inflammatoryresponseis

com-promisedinthosepatients,thusfewornosignsmaybefound. Sometimes fever may be the only complaint. In this con-text,theclinicalconditionofFebrileNeutropeniaisdefined asthedetectionofasingleoraltemperaturemeasurement of≥38.3◦Coratemperatureof≥38◦Csustainedoveraone

hour-periodinthe presenceofanANC≤500neutrophils/␮L

oranANCthatisexpectedtodecreaseto≤500neutrophils/␮L

duringthenext 48h.Inaddition,neutropenicpatientswho areafebrilebuthavesignsorsymptomsofinfectionshould beequallymanagedasfebrileneutropenicpatients.Prompt recognitionandtreatmentofanyinfectiousprocessiscrucial sincetheclinicalstatusmayrapidlydeterioratetosepsisand death.2

Correct evaluation of patients includes detailed anam-nesis, meticulous physical exams and laboratory tests to determine the severity of the complication and to locate the source of infection. Low-risk patients are those who haveestimatedneutropeniaforno longer than sevendays and no organ failures. In contrast, high-risk patients are thosewithanticipatedprolongedneutropenia,profound neu-tropenia(ANC≤100neutrophils/␮L)and/orclinicalconditions

suchashypotension,pneumonia,neurologicalsymptomsand abdominalpain. Theindex from the Multinational Associ-ation forSupportiveCareinCancer maybe usedasa risk assessmenttoolwithhighsensitivityandspecificity.3Ofnote,

all high risk patients should be admitted to the hospital andreceiveempiricalintravenouslargespectrumantibiotic therapy.2

Thephysicianmust carefully evaluatethe complaint of abdominalpaininaneutropenicpatientsinceitmayalertfor theoccurrenceofaseveregastrointestinalinfection.Indeed, signs of peritonitis during the evaluation may represent complicationssuchastyphlitis, pseudomembranouscolitis orothercausesofacuteabdomen.4,5Patientsmustalsohave

their perianal region checked for anorectal diseases and

flogosis.Rectalexam should notbeneglectedand invasive proceduresmustbetakenwiththeappropriateconsideration oftheriskofbacterialtranslocationanddiseaseworsening.6

Neutropenic

enterocolitis

Classically known astyphlitis or ileocecal syndrome, neu-tropenic enterocolitis is anecrotizing polymicrobialcolitis, diagnosedalmostexclusivelyinpatientswithneutropenia.7

Theword“typhlon”meanscecuminGreek,neverthelessthe terminal ileumand the whole colon may bealsoaffected. Although this condition is often described as necrotizing enterocolitis,theclinicalpicturemayvaryfromamild, non-necrotizingform,toaseveretransmuralprocesswithahigh riskofdeath.8

Neutropenicenterocolitishasbeenhistoricallyreportedas themostcommongastrointestinalcomplicationinpatients with fever, neutropenia and abdominal pain, affecting as muchas50%ofsuchpatients,whichmortalityratesthatvary from20to50%.9,10

The genesis of this complication waits for complete understanding, however some factors may be involved: chemotherapy cytotoxic effects, damage of gut mucosa, immunosuppression and translocationofvirulent microor-ganisms. The pathologic result is gangrenous necrosis, subserosalgasaccumulationandperforationoftheaffected segment,duetointestinalinfarction.4

Thediagnosisoftyphlitisshouldbepresumedinpatients withsevereneutropenia,abdominalpain(rightlower quad-rant) and fever. Physical exam may evidence abdominal distention and tenderness. Differential diagnosis includes acute appendicitis, psoas abscess and pseudomembranous colitis.5,11Computedtomographyusuallysealsthediagnosis

by revealing thick and dilated bowel walls with mesen-teric stranding.12 Plain films of the abdomen can be used

to detect pneumoperitoneum. Invasive procedures suchas colonoscopy and bariumenema may cause bowel perfora-tionandshouldnotbeattempted.Aflexiblesigmoidoscopy and C. difficile assays may be necessary to rule out pseu-domembranouscolitisinapatientwithimportantdiarrhea associated to abdominal distention and recent history of antibiotictherapy.13

Medicaltreatmentofuncomplicatedtyphlitisconsistsof broad-spectrum antibiotics,bowelrest,nasogastricsuction, hydroeletroliticadjustmentandanemiacorrection(Fig.1).To choose the right empiric antibioticregimen, the physician must:(1)considerthepolymicrobialnatureoftheinfection; (2)evaluatethepatient’sriskfactorsforcomplicatedoutcome; and(3)knowthelocalresistanceofpathogens.2,14Cefepime,

(3)

jcoloproctol(rioj).2014;34(3):189–192

191

1. Bowel rest 2. Nasogastric suction 3. Parenteral nutrition 4. Hydroeletrolitic adjustment 5. Correction of cytopenias and coagulopathy

6. Broad spectrum antibiotic therapy

Medical management

Unstable Patient Stable Patient

Hemorrhage Hemodynamic instability Pneumoperitoneum

No improvement to medical therapy

Laparotomy

Fig.1–Neutropenicenterocolitismanagement.

suspectedeitherbybloodculturesorpreviouspatient’s colo-nization,theadditionofanaminoglycosideisrecommended. Theuseofacarbapenemorpiperacillin-tazobactamisalso acceptableasfirstlinetherapy.Metronidazoleorvancomycin shouldbeaddedforsuspectedC.difficileinfection.Theuseof antifungaltherapycanbealsoadvisedinindividualcaseswith persistentand long-termneutropenia andrefractoriness to theantibacterialagent.Finally,supportivecarewith transfu-sionstoimproveanemia,thrombocytopeniaandcoagulation defectsaswellastheuseofgranulocytestimulatingfactors or granulocyteinfusionsshould bealso beconsidered and individualizedtoeachpatient.

Thediseaseisconsideredascomplicatedinthepresence ofbowelperforationwithperitonitis,gastrointestinal hemor-rhageordeteriorationoftheclinicalstatus(suchassepsisor organperfusionimpairment).Forthosecases,surgeryisthe onlyoptionandpatient’slifedependsontheabilityofthe sur-geontoidentifyandremovealldevitalizedtissue.15Usually,a

righthemicolectomywithaterminalileostomyandmucous fistulaappearsto beareasonableoptiongiventhe serious natureofthediseaseatthispoint.16

Anorectal

diseases

Neutropenicpatientsaresusceptibletoanyanorectaldisease. Perianalinfection(representedbyanabscessorinfected fis-tula)isthe mostfeared complication, consideringthe lack ofnaturaldefenseagainstinfectiousmicroorganisms. Man-ifestationsmaydifferfromthosewithacompetentimmune systemandincludemildtosevereanorectalpain,feveranda poorlydefinedindurationoftheanalcanal.Perianalinfection isalife-threateningcomplicationthatrequiresready diagno-sisandinterventionasrecurrenceandmortalityratesmaybe expressive.17Inaseriesof92patientswithacuteorchronic

leukemia,themostcommonmanifestationswereperirectal abscess(27%),followedbyanalfissures(23%),external hem-orrhoids(19%)andperianalulcerations(13%).Only16%ofthe patientsrequiredsurgerymostcommonlytodrain perirec-talabscesses.18Anotherretrospectivestudyof1102patients

foundaperianalinfectionprevalenceof6.7%.Recurrencewas diagnosedin31%ofthecasesand34%ofthepatientsreceived surgicalintervention.19

Conservativemeasuresconsistofsystemicantibiotics,sitz baths,stoolsoftenersandproperanalhygiene.Spectrumof antibioticcoverageshouldbebroadgiventhepolymicrobial

nature of the Infection. In a review of 963 cases of bone marrowtransplantation,themostcommonmicroorganisms wereEscherichiacoli,Bacteroides,Enterococcus,andKlebsiella.20

Surgeryharborstherisksofuncontrolledbleedingandpoor healingbutmaybetheonlychoiceforabscessesandfistulas. Ifanyoperationistobeconsidered,commonsensedictates thedecisiononholdingthechemotherapy.

Conclusions

Patients with neutropenia are predisposed to a variety of infectiousdiseases.Promptrecognitionandearlytreatment ofsuchcomplicationsareessentialforsurvival.Much atten-tionshouldbepaidtotheabdomen,perineumandanorectal area,sincetheycanbethesitesofinfection.Thediagnosis ofneutropenicenterocolitis,anorectalabscesses,orfistulas requires immediateconsultationwithacolorectal surgeon, even though medicalmanagement may be sufficient fora significantportionofcases.Inthepresenceofuncontrolled sepsis, bowel wall perforation, continuous gastrointestinal hemorrhage,surgerybecomesthelastresourceandlifewill dependonthesurgeon’sknife.

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

r

e

f

e

r

e

n

c

e

s

1.KeidanRD,FanningJ,GatenbyRA,WeeseJL.Recurrent typhlitis.Adiseaseresultingfromaggressivechemotherapy. DisColonRectum.1989;32:206–9.

2.FreifeldAG,BowEJ,SepkowitzKA,BoeckhMJ,ItoJI,Mullen CA,etal.Clinicalpracticeguidelinefortheuseof

antimicrobialagentsinneutropenicpatientswithcancer: updatebytheInfectiousDiseasesSocietyofAmerica.Clin InfectDis.2010;52:427–31.

3.UysA,RapoportBL,AndersonR.Febrileneutropenia:a prospectivestudytovalidatetheMultinationalAssociationof SupportiveCareofCancer(MASCC)risk-indexscore.Support CareCancer.2004;12:555–60[Epub2004].

4.KatzJA,WagnerML,GresikMV,MahoneyJuniorDH,Fernbach DJ.Typhlitis.An18-yearexperienceandpostmortemreview. Cancer.1990;65:1041–7.

5.WadeDS,NavaHR,DouglassHO.Neutropenicenterocolitis clinicaldiagnosisandtreatment.Cancer.1992;69:17–23.

6.GrewalH,GuillemJG,QuanSH,EnkerWE,CohenAM. AnorectaldiseaseinneutropenicleukemicpatientsOperative vs.nonoperativemanagement.DisColonRectum.

1994;37:1095–9.

7.RolstonKV,BodeyGP,SafdarA.Polymicrobialinfectionin patientswithcancer:anunderappreciatedand

underreportedentity.ClinInfectDis.2007;45:228–33.

8.BremerCT,MonahanBP.Necrotizingenterocolitisin neutropeniaandchemotherapy:aclinicalupdateandold lessonsrelearned.CurrGastroenterolRep.2006;8:333–41.

(4)

192

jcoloproctol(rioj).2014;34(3):189–192

10.CardonaAF,RamosPL,CasasbuenasA.Fromcasereportsto systematicreviewsinneutropenicenterocolitis.EurJ Haematol.2005;75:445–6.

11.deBritoD,BartonE,SpearsKL,CranmerHH,KarpSJ,Anglin D,etal.Acuterightlowerquadrantpaininapatientwith leukemia.AnnEmergMed.1998;32:98–101.

12.KirkpatrickID,GreenbergHM.Gastrointestinalcomplications intheneutropenicpatient:characterizationand

differentiationwithabdominalCT.Radiology.2003;226:668–74 [Epub2003].

13.KellyCP,PothoulakisC,LaMontJT.Clostridiumdifficilecolitis. NEnglJMed.1994;330:257–62.

14.AverbuchD,OraschC,CordonnierC,LivermoreDM,Mikulska M,ViscoliC,etal.ECIL4,ajointventureofEBMT,EORTC, ICHS,ESGICH/ESCMIDandELN.Europeanguidelinesfor empiricalantibacterialtherapyforfebrileneutropenic patientsintheeraofgrowingresistance:summaryofthe 20114thEuropeanConferenceonInfectionsinLeukemia. Haematologica.2013;98(December(12)):1826–35,

http://dx.doi.org/10.3324/haematol.2013.091025[Erratumin: Haematologica.2014;99:400].

15.ShambergerRC,WeinsteinHJ,DeloreyMJ,LeveyRH.The medicalandsurgicalmanagementoftyphlitisinchildren withacutenonlymphocytic(myelogenous)leukemia.Cancer. 1986;57:603.

16.MoirCR,ScudamoreCH,BennyWB.Typhlitis:selective surgicalmanagement.AmJSurg.1986;151:563–6.

17.BarnesSG,SattlerFR,BallardJO.Perirectalinfectionsinacute leukemiaImprovedsurvivalafterincisionanddebridement. AnnInternMed.1984;100:515–8.

18.NorthJH,WeberTK,Rodriguez-BigasMA,MeropolNJ,Petrelli NJ.Themanagementofinfectiousandnoninfectious anorectalcomplicationsinpatientswithleukemia.JAmColl Surg.1996;183:322–8.

19.ChenCY,ChengA,HuangSY,ShengWH,LiuJH,KoBS,etal. Clinicalandmicrobiologicalcharacteristicsofperianal infectionsinadultpatientswithacuteleukemia.PLOSONE. 2013;8:e60624,http://dx.doi.org/10.1371/journal.pone.0060624

[Epub2013].

Imagem

Fig. 1 – Neutropenic enterocolitis management.

Referências

Documentos relacionados

Of the five patients who did not achieve a primary healing in this study, all showed recurrence in the incision for ligation of the fistulous tract, i.e., their defects turned

per capita lower than 1 minimum wage, a poor health state, body dissatisfaction, physical.. activity during personal commuting and self-report

We present a case of a retrorectal hamartoma cystic in a young male patient, who debuted with a perianal abscess and was surgically treated using a transanal approach.. We con-

Colorectal lesions, ini- tially approached by endoscopic mucosal resection en bloc or in fragments, are the current focus for submucosal approach, especially for superficial

Impact of robotic surgery on sexual and urinary functions after fully robotic nerve-sparing total mesorectal excision for rectal cancer. D’Annibale A, Pernazza G, Monsellato I, Pende

To analyze the epidemiological profile of patients with inflam- matory bowel disease using biological therapy treated at the Coloproctology Service, Hospital Universitário

Although there is consis- tent data in the literature on high risk for clinical and surgical recurrence, previous bowel resections were not considered a risk factor for

Disposable single-port surgery devices have been used for transanal minimally invasive surgery (TAMIS) with benefits, when compared to local resection and transanal